Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.

Idborg, H., Zandian, A., Sandberg, A. S., Nilsson, B., Elvin, K., Truedsson, L., … Jakobsson, P. J. (2019). Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives. Arthritis research & therapy, 21(1), 62.

Date

Mon, 18/02/2019 - 12:00

PubMed ID

30777133

Author(s)

Idborg H, Zandian A, Sandberg AS, Nilsson B, Elvin K, Truedsson L, Sohrabian A, Rönnelid J, Mo J, Grosso G, Kvarnström M, Gunnarsson I, Lehtiö J, Nilsson P, Svenungsson E, Jakobsson PJ.

Year

2019

EFPIA partners

AstraZeneca